Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MDNA - Medicenna Therapeutics Corp.'s (MDNA) CEO Dr. Fahar Merchant on Q4 2021 Results - Earnings Call Transcript

MDNA - Medicenna Therapeutics Corp.'s (MDNA) CEO Dr. Fahar Merchant on Q4 2021 Results - Earnings Call Transcript

Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. (MDNA) Q4 2021 Earnings Conference Call May 28, 2021, 8:30 AM ET Company Participants Dan Ferry - LifeSci Advisors, IR Dr. Fahar Merchant - President and CEO Dr. Mann Muhsin - Chief Medical Officer Dr. Kevin Moulder - Chief Scientific Officer Mina Merchant - Chief Development Officer Liz Williams - Chief Financial Officer Conference Call Participants Matt Biegler - Oppenheimer RK Ramakanth - H.C. Wainwright Kumar Raja - Brookline Capital Markets David Bautz - Zacks Small-Cap Research Presentation Operator Hello. And welcome to Medicenna Therapeutics Fiscal Year 2021 Earnings Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised this call is being recorded at the company’s request. I would now like to turn the call over to Dan Ferry of LifeSci Advisors. Please go ahead. Dan Ferry Thank you, Operator, and thank

For further details see:

Medicenna Therapeutics Corp.'s (MDNA) CEO Dr. Fahar Merchant on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Medicenna Therapeutics Corp.
Stock Symbol: MDNA
Market: NASDAQ
Menu
MDNA MDNA Quote MDNA Short MDNA News MDNA Articles MDNA Message Board
Get MDNA Alerts

News, Short Squeeze, Breakout and More Instantly...